Feb 13 (Reuters) - Advisers to the U.S. Food and Drug Administration on Tuesday recommended approval of Abbott Laboratories' heart valve repair device that is designed for patients who are at risk of complications or death during surgery. (Reporting by Leroy Leo and Puyaan Singh in Bengaluru; Editing by Shinjini Ganguli)